Itama Ranoraya Cash Flow Conversion Efficiency
Itama Ranoraya cash flow conversion efficiency. Based on the latest financial reports, Itama Ranoraya (IRRA) has a cash flow conversion efficiency ratio of -0.502x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp-270.56 Billion ≈ $-15.85 Million USD) by net assets (Rp538.82 Billion ≈ $31.57 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Itama Ranoraya (2016–2024)
Cash flow conversion efficiency of Itama Ranoraya from 2016 to 2024. This chart illustrates how Itama Ranoraya's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Itama Ranoraya for real-time trading data and today's change.
Itama Ranoraya Cash Flow Conversion Ratio Explained
Itama Ranoraya cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Itama Ranoraya Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Itama Ranoraya ranked by their cash flow conversion efficiency. Also see Itama Ranoraya stock valuation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Trajectory Alpha Acquisition Corp
NYSE:TCOA
|
-0.004x |
|
Apex Equity Holdings Bhd
KLSE:5088
|
0.143x |
|
Black Canyon Ltd
AU:BCA
|
-0.044x |
|
Sun Race Sturmey-Archer Inc
TW:1526
|
0.044x |
|
Vulcan Minerals Inc.
V:VUL
|
-0.003x |
|
Pyung Hwa Hldg
KO:010770
|
0.224x |
|
Shinfox Energy Co Ltd
TW:6806
|
0.649x |
|
Alakasa Industrindo Tbk
JK:ALKA
|
0.034x |
Annual Cash Flow Conversion Efficiency for Itama Ranoraya (2016–2024)
The table below shows the annual cash flow conversion efficiency of Itama Ranoraya from 2016 to 2024. Review Itama Ranoraya (IRRA) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Rp512.31 Billion ≈ $30.02 Million |
Rp-430.13 Billion ≈ $-25.20 Million |
-0.840x | -924.52% |
| 2023-12-31 | Rp459.20 Billion ≈ $26.91 Million |
Rp-37.63 Billion ≈ $-2.21 Million |
-0.082x | -171.33% |
| 2022-12-31 | Rp484.04 Billion ≈ $28.36 Million |
Rp55.61 Billion ≈ $3.26 Million |
0.115x | +153.99% |
| 2021-12-31 | Rp502.05 Billion ≈ $29.42 Million |
Rp-106.83 Billion ≈ $-6.26 Million |
-0.213x | -135.06% |
| 2020-12-31 | Rp242.33 Billion ≈ $14.20 Million |
Rp147.09 Billion ≈ $8.62 Million |
0.607x | +1844.88% |
| 2019-12-31 | Rp235.17 Billion ≈ $13.78 Million |
Rp-8.18 Billion ≈ $-479.35K |
-0.035x | +74.92% |
| 2018-12-31 | Rp66.64 Billion ≈ $3.91 Million |
Rp-9.25 Billion ≈ $-541.73K |
-0.139x | -119.52% |
| 2017-12-31 | Rp44.35 Billion ≈ $2.60 Million |
Rp31.51 Billion ≈ $1.85 Million |
0.711x | +619.39% |
| 2016-12-31 | Rp10.78 Billion ≈ $631.71K |
Rp1.06 Billion ≈ $62.40K |
0.099x | -- |
About Itama Ranoraya
PT Itama Ranoraya Tbk wholesale trades in laboratory and pharmaceutical equipment, and medical devices for humans in Indonesia. The company offers in vitro diagnostics products comprising rapid test and clinical laboratory; medical imaging products, including bone densitometer, C-arm, flat panel digital detector, mobile and stationary x-ray, and mammography; cardiovascular, urology, and surgical … Read more